Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhC1INH for Acute HAE Attacks
NCT00225147Phase 3Completed
- Sponsor
- Pharming Group
- Start
- Jul 2005
- Primary completion
- Oct 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of c1-esterase inhibitor in hereditary angioedema (HAE), sponsored by Pharming Group. Started Jul 2005; status: completed.
02
Drugs
c1-esterase inhibitor
03
Conditions
hereditary angioedema (HAE)
Beyond the preview
Go deeper on NCT00225147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225147.